CORONA VIRUS : THE SILENT KILLER

Irkar jotiram S; Barate sushil; Yelurkar dipratna; Renuka R. Deshpande

CORONA VIRUS : THE SILENT KILLER

Authors: Irkar jotiram S, Barate sushil, Yelurkar dipratna, Renuka R. Deshpande

Unique Paper ID: 149477
Volume: 6
Issue: 12
PageNo: 509-513

Keywords: Novel corona virus COVID 19outbreak Pathogenesis pandemic Diagnosis Treatment

Abstract:
The corona virus disease covid-19 is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 SARS-CoV-2), which emerged in Wuhan, China and spread around the world. Genomic analysis revealed that SARS-Co-V-2 is phylogenetically related to severe acute respiratory syndrome like (SARS-like-viruses.It can be transferred from human to human has been confirmed widely. There is no clinically approved antiviral drug or vaccine available to be used against COVID-19 in clinical trials, resulted in clinical recovery. World health organisation ( WHO) officially declared the COVID-19 epedemic as a public health emergency of international concern. According to the world health issue to public health its transmission via droplets, contaminated hands or surfaces. Early diagnosis, quarantine, and supportive treatments are essential to cure patients.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 6
Issue: 12
PageNo: 509-513

CORONA VIRUS : THE SILENT KILLER

Available:https://ijirt.org/Article?manuscript=149477

11 Jan, 2022

EVALUATION OF MARKETED EFFERVESCENT TABLETS

13 Oct, 2021

Bacterial Biofilm Inhibitor

02 Aug, 2021

The risk of death caused by the use of norepinephrine-resistant hypotension in the condition of septic shock in a patient

02 Aug, 2021

COMPUTER AIDED DRUG DESIGN (CADD)

29 Jul, 2021

Impact : Of Second Wave Covid-19 In world

29 Jul, 2021

The use of milrinone for curing a chronic heart failure

26 Jul, 2021

Leprosy Disease review

20 Jul, 2021

Transdermal Drug Delivery System

13 Jul, 2021

IBUPROFEN: AN OVERVIEW

13 Jul, 2021

CHEMOTHERAPY FOR BREAST CANCER

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry